Target intelligence / Profile preview

TNF receptor-associated factor 6 pseudogene 1 (TRAF6P1)

Target
TRAF6P1
Molecular classification
Pseudogene
01

Overview

TNF receptor-associated factor 6 pseudogene 1 (TRAF6P1) is a noncoding genomic locus in humans that closely resembles the functional gene TRAF6 but does not encode a functional protein[4][5][6]. Pseudogenes like TRAF6P1 are generally considered biologically inconsequential, although emerging research on other pseudogenes suggests some may participate in gene regulation by acting as microRNA decoys or producing regulatory RNAs in certain cellular contexts[1][2][3]. No scientific literature specifically implicates TRAF6P1 in disease or regulatory biology, nor is it viewed as a traditional drug target in pharmacology[4][5][6]. In summary: - TRAF6P1 is a pseudogene and not a canonical therapeutic target. - "TNF receptor-associated factor 6 pseudogene 1" is its canonical name, with TRAF6P1 as the standard abbreviation. - There is no evidence for functional, regulatory, or pathological roles comparable to those described for pseudogenes like PTENP1 or KRASP1[1][2][3]. - There are no interacting drugs, mechanisms of action, biomarker roles, or safety concerns documented for TRAF6P1.

Other names
TRAF6 pseudogene 1
02

Mechanism of action

Not applicable; there are no known drugs or mechanisms targeting TRAF6P1.

03

Biological functions

No well-established biochemical functionRegulatory non-coding RNA (potential, not confirmed for TRAF6P1)
04

Disease associations

No specific disease role attributed
05

Safety considerations

None relevant; as a nonfunctional pseudogene, TRAF6P1 does not present direct safety issues.

Beyond the preview

Go deeper on TNF receptor-associated factor 6 pseudogene 1 (TRAF6P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TNF receptor-associated factor 6 pseudogene 1 (TRAF6P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call